未登录
分享
收藏
分享
收藏How Does Mg2+ (aq) Interact with ATP(aq)? Biomolecular Structure through the Lens of Liquid-Jet Photoemission SpectroscopyMg2 (aq) 如何与ATP(aq) 相互作用?通过液体喷射光发射光谱透镜的生物分子结构
Mudryk, Karen; Lee, Chin; Tomanik, Lukas; Malerz, Sebastian; Trinter, Florian; Hergenhahn, Uwe; Neumark, Daniel M.; Slavicek, Petr; Bradforth, Stephen; Winter, Bernd
分享
收藏
分享
收藏
分享
收藏
分享
收藏Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial布鲁顿酪氨酸激酶抑制剂Fenebrutinib (GDC-0853) 治疗系统性红斑狼疮的疗效、安全性和药效学作用: 一项II期、随机、双盲、安慰剂对照试验的结果
Isenberg, David; Furie, Richard; Jones, Nicholas S.; Guibord, Pascal; Galanter, Joshua; Lee, Chin; McGregor, Anna; Toth, Balazs; Rae, Julie; Hwang, Olivia; Desai, Rupal; Lokku, Armend; Ramamoorthi, Nandhini; Hackney, Jason A.; Miranda, Pedro; de Souza, Viviane A.; Jaller-Raad, Juan J.; Fernandes, Anna Maura; Salinas, Rodrigo Garcia; Chinn, Leslie W.; Townsend, Michael J.; Morimoto, Alyssa M.; Tuckwell, Katie
分享
收藏
分享
收藏Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, PhaseIITrial
Cohen, Stanley; Tuckwell, Katie; Katsumoto, Tamiko R.; Zhao, Rui; Galanter, Joshua; Lee, Chin; Rae, Julie; Toth, Balazs; Ramamoorthi, Nandhini; Hackney, Jason A.; Berman, Alberto; Damjanov, Nemanja; Fedkov, Dmytro; Jeka, Slawomir; Chinn, Leslie W.; Townsend, Michael J.; Morimoto, Alyssa M.; Genovese, Mark C.
分享
收藏
分享
收藏
分享
收藏Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trialIxekizumab用于治疗活动性银屑病关节炎和对肿瘤坏死因子抑制剂反应不足的患者: 来自SPIRIT-P2 3期试验的24周随机,双盲,安慰剂对照期的结果
Nash, Peter; Kirkham, Bruce; Okada, Masato; Rahman, Proton; Combe, Benard; Burmester, Gerd-Ruediger; Adams, David H.; Kerr, Lisa; Lee, Chin; Shuler, Catherine L.; Genovese, Mark
分享
收藏
分享
收藏Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study
Smolen, Josef S.; Weinblatt, Michael E.; van der Heijde, Desiree; Rigby, William F. C.; van Vollenhoven, Ronald; Bingham, Clifton O., III; Veenhuizen, Melissa; Gill, Anne; Zhao, Fangyi; Komocsar, Wendy J.; Berclaz, Pierre-Yves; Ortmann, Robert; Lee, Chin
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏